Abstract: A multi-subscriber identification module (SIM) device is provided, and includes first and second SIMs, first and second radio frequency (RF) resources, and a baseband processor. The first and second SIMs are for using first and second services of first and second networks respectively. The first RF resource supports a non-limiting channel configuration use in accordance with a radio resource control (RRC) protocol. The second RF resource supports a limiting channel configuration use in accordance with the RRC protocol. The baseband processor, in a dual radio (DR) mode, configures one of the first and second SIMs as a main SIM based on information on the first and second networks, allots the first RF resource to the main SIM, configures the other one as a sub-SIM, and allots the second RF resource to the sub-SIM.

Abstract: A multi-subscriber identification module (SIM) device is provided, and includes first and second SIMs, first and second radio frequency (RF) resources, and a baseband processor. The first and second SIMs are for using first and second services of first and second networks respectively. The first RF resource supports a non-limiting channel configuration use in accordance with a radio resource control (RRC) protocol. The second RF resource supports a limiting channel configuration use in accordance with the RRC protocol. The baseband processor, in a dual radio (DR) mode, configures one of the first and second SIMs as a main SIM based on information on the first and second networks, allots the first RF resource to the main SIM, configures the other one as a sub-SIM, and allots the second RF resource to the sub-SIM.

Abstract: The present invention provides a pharmaceutical composition for preventing or treating learning disorders, memory disorders, Parkinson's disease, or ischemic cerebrovascular disease, which comprises a ginger extract or shogaol; and a pharmaceutically acceptable carrier. And also, the present invention provides a food composition for improving learning disorders or memory disorders or alleviating the symptoms of learning disorders or memory disorders which comprises a ginger extract or shogaol as an active ingredient, or a food composition for improving learning or memory which comprises a ginger extract or shogaol as an active ingredient.

Abstract: The present invention provides a pharmaceutical composition for preventing or treating learning disorders, memory disorders, Parkinson's disease, or ischemic cerebrovascular disease, which comprises a ginger extract or shogaol; and a pharmaceutically acceptable carrier. And also, the present invention provides a food composition for improving learning disorders or memory disorders or alleviating the symptoms of learning disorders or memory disorders which comprises a ginger extract or shogaol as an active ingredient, or a food composition for improving learning or memory which comprises a ginger extract or shogaol as an active ingredient.

Abstract: A process for preparing a processed ginseng extract with enhanced pharmacological effects due to subsequent treatment is disclosed. The subsequent treatment includes an acid-treatment of ginseng and a bio-converting treatment, such as a lactic acid bacterial fermenting and an intestinal bacterial fermenting process.

Abstract: The present invention relates to novel use of the extract of processed ginseng extract having brain stroke protecting or treating activity. More particularly, the present invention relates to a processed ginseng extract with enhanced pharmacological effects due to subsequent treatment i.e., acid-treatment of ginseng and bio-converting treatment such as lactic acid bacterial fermenting and intestinal bacterial fermenting process. The processed ginseng extract in the present invention has preventing or treating effect for brain stroke. Therefore, it is useful in the prevention or treatment of brain stroke and brain diseases in human or mammal.